Michael Drass, MD
Pain Medicine · Altoona, PANPI 1225144520
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,702 and has fallen 64.9% since, to $947 in 2025. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 397 payments — averaging $30.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$2K
- Medtronic$2K
- Relievant Medsystems, Inc.$1K
- AbbVie$625
- Collegium Pharmaceutical, Inc.$486
- plus $3K from 31 others
What the payments were for
- Travel & lodging$5705%
- Food & beverage$11,54395%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 100 | $2,806 |
| Abbott | 51 | $1,969 |
| Medtronic(2 entities) | 31 | $1,701 |
| Relievant Medsystems, Inc. | 21 | $1,346 |
| AbbVie(2 entities) | 38 | $625 |
| Collegium Pharmaceutical, Inc. | 29 | $486 |
| MML US, Inc. | 9 | $359 |
| Foundation Fusion Solutions, LLC | 8 | $271 |
| Lundbeck LLC | 15 | $229 |
| Bioventus LLC | 5 | $226 |
| SPR Therapeutics, Inc | 3 | $219 |
| Nevro Corp. | 8 | $213 |
| Vertos Medical, Inc. | 7 | $201 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $164 |
| Averitas Pharma Inc. | 7 | $159 |
| Pfizer | 10 | $158 |
| MDD US Operations, LLC | 9 | $145 |
| GRT US Holding, Inc. | 4 | $106 |
| Si-bone, Inc. | 6 | $101 |
| Spinal Simplicity, LLC | 2 | $82 |
| Biodelivery Sciences International, Inc. | 1 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $72 |
| Vertex | 4 | $65 |
| Valinor Pharma, LLC | 3 | $55 |
| Merz Pharmaceuticals, LLC | 1 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Painteq LLC | 1 | $28 |
| Globus Medical | 1 | $26 |
| Appliedvr Inc | 1 | $26 |
| Amgen | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Acelrx Pharmaceuticals, Inc. | 1 | $14 |
| Trice Medical, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,900
- INTELLIS ADAPTIVESTIM$385
- ADAPTIVESTIM$222
- GENERAL PAIN MANAGEMENT$218
- PRECISION$216
- ReActiv8$136
- SUPERION$135
- WaveWriter Alpha Prime 16$134
- Stimrouter Implantable Kit$122
- Proclaim IPG$114
- INFINION$112
- INCEPTIV$103
- PROCLAIM$102
How this compares
$12,113 in reported general payments places this provider in the 90th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 103 | $145,139 |
| OxycontinOxycodone Hcl | 115 | $138,851 |
| RelistorMethylnaltrexone Bromide | 13 | $30,454 |
| NucyntaTapentadol Hcl | 22 | $23,213 |
| Fentanyl | 100 | $19,286 |
| Nurtec OdtRimegepant Sulfate | 19 | $19,057 |
| Morphine Sulfate ErMorphine Sulfate | 451 | $18,415 |
| MovantikNaloxegol Oxalate | 31 | $17,281 |
| Nucynta ErTapentadol Hcl | 11 | $17,164 |
| Oxymorphone Hcl ErOxymorphone Hcl | 22 | $11,397 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 466 | $7,556 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 281 | $7,459 |
| Gabapentin | 518 | $5,778 |
| Buprenorphine | 19 | $3,591 |
| Oxycodone Hcl | 188 | $3,560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er | $486 | $185,517136 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $164 | $30,45413 claims |
| PfizerNurtec Odt | $158 | $19,05719 claims |
| Redhill Biopharma Inc.Movantik | $15 | $17,28131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 294 pain medicine providers in Pennsylvania.
Other pain medicine in Altoona
- Nicholas KinbackAltoona$16K
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
- Philip KimBryn Mawr$128K
- Ajay WasanPittsburgh$66K
- Sanjay ShahSpring House$64K
- Soon JungAllentown$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.